Inotiv Operating Margin from 2010 to 2024
| NOTV Stock | USD 3.41 0.20 6.23% |
Check Inotiv financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inotiv's main balance sheet or income statement drivers, such as Depreciation And Amortization of 66.1 M, Interest Expense of 23.5 M or Selling General Administrative of 130.7 M, as well as many indicators such as Price To Sales Ratio of 0.12, Dividend Yield of 0.0029 or PTB Ratio of 0.25. Inotiv financial statements analysis is a perfect complement when working with Inotiv Valuation or Volatility modules.
Inotiv | Operating Margin |
Latest Inotiv's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Inotiv Inc over the last few years. It is Inotiv's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inotiv's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.17) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Inotiv Operating Margin Regression Statistics
| Arithmetic Mean | (0.05) | |
| Geometric Mean | 0.04 | |
| Coefficient Of Variation | (203.84) | |
| Mean Deviation | 0.08 | |
| Median | (0) | |
| Standard Deviation | 0.09 | |
| Sample Variance | 0.01 | |
| Range | 0.2754 | |
| R-Value | (0.43) | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.18 | |
| Significance | 0.11 | |
| Slope | (0.01) | |
| Total Sum of Squares | 0.12 |
Inotiv Operating Margin History
About Inotiv Financial Statements
Inotiv investors use historical fundamental indicators, such as Inotiv's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Inotiv. Please read more on our technical analysis and fundamental analysis pages.
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries and sells analytical instruments to the pharmaceutical development and contract research industries. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana. Inotiv operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 541 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Inotiv Stock Analysis
When running Inotiv's price analysis, check to measure Inotiv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inotiv is operating at the current time. Most of Inotiv's value examination focuses on studying past and present price action to predict the probability of Inotiv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inotiv's price. Additionally, you may evaluate how the addition of Inotiv to your portfolios can decrease your overall portfolio volatility.